Bone health and treatments
Moving in Journal of Clinical Oncology, Leukemia, European Urology, Clinical Cancer Research, Med, Autophagy, bioRxiv and JNCI: Journal of the National Cancer Institute.
- Moved, week to 17 Nov 2026
- 0
- Papers in 60 days
- 24
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Bone health and treatments
Newest first · last 60 days
AI summary · may contain errors
Projected long-term progression-free survival is substantially longer with DVRd than VRd in newly diagnosed multiple myeloma, with best-fit median PFS 205 vs 87 months in transplant-eligible patients.
AI summary · may contain errors
In the prospective BoHemE study, patients with myelodysplastic neoplasms (n=111) had lower baseline bone mineral density T-scores than age-matched controls, especially in women.
- Open access
AI summary · may contain errors
Tumor-derived CTHRC1 promotes osteoclast differentiation in prostate cancer bone metastasis, driving osteolytic lesion development via an ITGB3-dependent mechanism in mouse models.
- Open access
AI summary · may contain errors
ASCO’s living guideline for systemic therapy in metastatic castration-resistant prostate cancer is continuously updated to reflect rapidly changing evidence and clinical practice needs.
- 1 cites
AI summary · may contain errors
In transplant-ineligible newly diagnosed multiple myeloma, daratumumab plus lenalidomide/dexamethasone improved median overall survival to 90.3 months versus 64.1 months with Rd (HR 0.67).
- Open access
AI summary · may contain errors
Zoledronic acid blocks secretory autophagy in osteoclasts by inhibiting autophagic flux and delaying autophagy-related protein degradation, preventing secretion of CTSK, ACP5/TRAP, and MMP9.
- Open access
- 1 cites
AI summary · may contain errors
In newly diagnosed multiple myeloma patients with renal impairment (creatinine clearance 15 to <60 mL/min), pomalidomide-bortezomib-dexamethasone achieved a higher ≥VGPR rate after 4 induction cycles (72.4% vs 20.8%).
- Open access
- 1 cites
AI summary · may contain errors
In a randomized phase 2 study of multiple myeloma with advanced renal failure, pomalidomide plus bortezomib and dexamethasone improves myeloma control and increases renal function after four cycles.
AI summary · may contain errors
Modified-intensity RVD-lite in transplant-ineligible multiple myeloma achieved a median PFS of 42 months and median OS of 76 months after 72 months’ follow-up.
AI summary · may contain errors
A bone metastasis signature (BMS) in plasma extracellular vesicles is linked to bone-tumour formation in men with M1b prostate cancer, with BMS genes rising up to 50 days before detectable growth.
- Open access
AI summary · may contain errors
ASCO Living Guidelines for multiple myeloma are continuously updated to reflect rapidly evolving evidence, with scheduled revisions by an expert panel.
- Open access
AI summary · may contain errors
In the transplant-ineligible subgroup of newly diagnosed multiple myeloma (N=289), daratumumab plus bortezomib, lenalidomide, and dexamethasone achieved 60.4% MRD negativity (10^-5) versus 39.3% with VRd.
- Open access
Browse JClub
Journals this month
- bioRxiv6426
- medRxiv1764
- PNAS556
- JAMA353
- Sci Adv330
- Cell Rep315
- Environ Res225
- BMJ217
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- Curr Biol148
- NEJM148
- New Phytol147
- Nature128
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
